Gibson Christopher - Insider Transactions
Insider Type
individual
Companies
1
Average
285,104
Total Txns
52
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 5 | -5 | 0.00 | 769,695.35 | -769,695.35 |
| 2024 | 0 | 34 | -34 | 0.00 | 7,661,553.18 | -7,661,553.18 |
| 2025 | 0 | 13 | -13 | 0.00 | 6,394,150.96 | -6,394,150.96 |
| Total: | 0 | 52 | 10 | 0.00 | 14,825,399.49 | -14,825,399.49 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
4.76 USD |
100,000 Sold |
476,000 USD |
25/09/2025 | 25/09/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
4.71 USD |
100,000 Sold |
471,000 USD |
10/09/2025 | 10/09/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
4.84 USD |
100,000 Sold |
484,000 USD |
26/08/2025 | 26/08/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
5.28 USD |
100,000 Sold |
528,000 USD |
11/08/2025 | 11/08/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
5.28 USD |
17,875 Sold |
94,380 USD |
11/08/2025 | 11/08/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
5.28 USD |
500,300 Sold |
2,641,584 USD |
11/08/2025 | 11/08/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.04 USD |
138,574 Sold |
836,987 USD |
27/03/2025 | 27/03/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.58 USD |
20,000 Sold |
131,600 USD |
05/03/2025 | 05/03/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.37 USD |
20,000 Sold |
127,400 USD |
05/03/2025 | 06/03/2025 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
8.12 USD |
20,000 Sold |
162,400 USD |
05/02/2025 | 06/02/2025 |